Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INNOVATE (VATE) Capital Expenditures: 2010-2024

Historic Capital Expenditures for INNOVATE (VATE) over the last 15 years, with Dec 2024 value amounting to $19.0 million.

  • INNOVATE's Capital Expenditures fell 33.33% to $200,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $19.2 million, marking a year-over-year increase of 300.00%. This contributed to the annual value of $19.0 million for FY2024, which is 3.26% up from last year.
  • Latest data reveals that INNOVATE reported Capital Expenditures of $19.0 million as of FY2024, which was up 3.26% from $18.4 million recorded in FY2023.
  • INNOVATE's Capital Expenditures' 5-year high stood at $24.1 million during FY2021, with a 5-year trough of $17.8 million in FY2020.
  • In the last 3 years, INNOVATE's Capital Expenditures had a median value of $19.0 million in 2024 and averaged $19.4 million.
  • As far as peak fluctuations go, INNOVATE's Capital Expenditures fell by 27.94% in 2020, and later surged by 35.39% in 2021.
  • Yearly analysis of 5 years shows INNOVATE's Capital Expenditures stood at $17.8 million in 2020, then spiked by 35.39% to $24.1 million in 2021, then fell by 14.11% to $20.7 million in 2022, then dropped by 11.11% to $18.4 million in 2023, then rose by 3.26% to $19.0 million in 2024.